Joachim Boos

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 601 citations · Full text

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

Frank Berthold, Joachim Boos, Stefan Burdach et al. · The Lancet Oncology · 2005 · 397 citations

Hematological Malignancy, Neuro-oncology, Cell Therapy +9

Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations

Joachim Boos, G. Werber, E. Ahlke et al. · European Journal of Cancer · 1996 · 217 citations

Asparaginase Activity, Asparagine Levels, Different Asparaginase Preparations

High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma

Jane Carr‐Wilkinson, K O’Toole, Katrina Wood et al. · Clinical Cancer Research · 2010 · 163 citations · Full text

Level of activity in children undergoing cancer treatment

Corinna Winter, Carsten Müller, Mirko Brandes et al. · Pediatric Blood & Cancer · 2009 · 151 citations